Ann Dermatol.  2019 Apr;31(2):256-259. 10.5021/ad.2019.31.2.256.

MiR-92a-1-5p and miR-328-3p Are Up-Regulated in Skin of Female Pattern Hair Loss Patients

• Aksenenko
• Palkina N
• Komina A
• Ruksha T

• KMID: 2439085
• DOI: http://doi.org/10.5021/ad.2019.31.2.256

Abstract

No abstract available.

MeSH Terms

Female*
Hair*
Humans
Skin*

Figure

• 

  Fig. 1 Clustering analysis of miRNA expression. The heat map illustrates the result of the two-way hierarchical clustering of miRNAs and samples. Each row represents one miRNA and each column represents one sample, including female pattern hair loss (FPHL) and control skin samples. The color scale illustrates the relative expression level of a miRNA across all samples: red color represents an expression level above the mean, green color represents expression lower than the mean. 1 - male group normal skin samples obtained from the interscapular zone of the thorax; 2 - female group including normal skin samples obtained from the scalp zone; 3 - FPHL patients group.

• 

  Fig. 2 Expression levels of miR-92a-1-5p and miR-328-3p in normal male, female skin, and female pattern hair loss (FPHL) patients' skin estimated by real-time polymerase chain reaction. *Significant differences compared to the control skin male. †Significant differences compared to the control skin female.

Reference

1. Yazdan P. Update on the genetics of androgenetic alopecia, female pattern hair loss, and alopecia areata: implications for molecular diagnostic testing. Semin Cutan Med Surg. 2012; 31:258–266.

2. Inui S, Itami S. Molecular basis of androgenetic alopecia: from androgen to paracrine mediators through dermal papilla. J Dermatol Sci. 2011; 61:1–6.

3. Randall VA, Jenner TJ, Hibberts NA, De Oliveira IO, Vafaee T. Stem cell factor/c-Kit signalling in normal and androgenetic alopecia hair follicles. J Endocrinol. 2008; 197:11–23.

4. Ahmed MI, Alam M, Emelianov VU, Poterlowicz K, Patel A, Sharov AA, et al. MicroRNA-214 controls skin and hair follicle development by modulating the activity of the Wnt pathway. J Cell Biol. 2014; 207:549–567.

5. Warshauer E, Samuelov L, Sarig O, Vodo D, Bindereif A, Kanaan M, et al. RBM28, a protein deficient in ANE syndrome, regulates hair follicle growth via miR-203 and p63. Exp Dermatol. 2015; 24:618–622.

6. Arias-Santiago S, Gutiérrez-Salmerón MT, Buendía-Eisman A, Girón-Prieto MS, Naranjo-Sintes R. Androgenetic alopecia as an early marker of benign prostatic hyperplasia. Acta Derm Venereol. 2010; 90:485–487.

7. Weilner S, Skalicky S, Salzer B, Keider V, Wagner M, Hildner F, et al. Differentially circulating miRNAs after recent osteoporotic fractures can influence osteogenic differentiation. Bone. 2015; 79:43–51.

8. Aslam A, Salam A, Griffiths CE, McGrath JA. Naevus sebaceus: a mosaic RASopathy. Clin Exp Dermatol. 2014; 39:1–6.

9. Tsai JH, Huang WC, Jhuang JY, Jeng YM, Cheng ML, Chiu HY, et al. Frequent activating HRAS mutations in trichilemmoma. Br J Dermatol. 2014; 171:1073–1077.

10. Golomb L, Sagiv A, Pateras IS, Maly A, Krizhanovsky V, Gorgoulis VG, et al. Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancy. Cell Death Differ. 2015; 22:1764–1774.